Product Information

LOTEPREDNOL ETABONATE 0.5% DRP is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $18.7123 per ML under NDC 70748030002. Its NADAC has been published 59 times since Oct 1, 2025.

FDA first approved this application on Apr 24, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LOTEPREDNOL ETABONATE 0.5% DRP

loteprednol etabonate
$18.7123per ML

Strength

5 mg/mL

NDC

70748030002

Classification

Generic

Dosage Form

SUSPENSION

Route

OPHTHALMIC

Effective Date

10/21/2026

Active Ingredients

LOTEPREDNOL ETABONATE

Approval Type

Generic (ANDA)

FDA Application

ANDA215719

FDA Approved

4/24/2024

TE Code

AB

On Market Since

7/1/2025

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for LOTEPREDNOL ETABONATE 0.5% DRP has been published 59 times since Oct 1, 2025, and over the history we have for it it has declined 7.7%. The table below summarizes its recorded NADAC range and movement.

Current price$18.7123 per ML
All-time high$22.0153 (Aug 12, 2026)
All-time low$18.7123 (Oct 21, 2026)
52-week high$22.0153
52-week low$18.7123
Median price$20.6883
Average price$20.5371
Largest weekly change-11.7% (Oct 21, 2026)
Weeks tracked59
Tracking sinceOct 1, 2025

Price History

1W

0.0%

1M

-11.7%

3M

-14.2%

6M

-7.5%

1Y

-7.9%

3Y

N/A

5Y

N/A

All

-7.7%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 44% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 44%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LOTEPREDNOL ETABONATE 0.5% DRP?

The current National Average Drug Acquisition Cost (NADAC) for LOTEPREDNOL ETABONATE 0.5% DRP, manufactured by Lupin Pharmaceuticals Inc., is $18.7123 per ML (NDC 70748030002), effective Nov 11, 2026.

How has the price of LOTEPREDNOL ETABONATE 0.5% DRP changed over time?

Over the history we have for it, the NADAC for LOTEPREDNOL ETABONATE 0.5% DRP has declined 7.7%. It has been tracked across 59 weekly CMS publications since Oct 1, 2025.

What are the highest and lowest recorded NADAC prices for LOTEPREDNOL ETABONATE 0.5% DRP?

Since Oct 1, 2025, the NADAC for LOTEPREDNOL ETABONATE 0.5% DRP has ranged from a low of $18.7123 (Oct 21, 2026) to a high of $22.0153 (Aug 12, 2026), with a median of $20.6883 per ML.

Are there cheaper alternatives to LOTEPREDNOL ETABONATE 0.5% DRP?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LOTEPREDNOL ETABONATE 0.5% DRP, is $10.4368 per ML — about 44% below LOTEPREDNOL ETABONATE 0.5% DRP.

Who manufactures LOTEPREDNOL ETABONATE 0.5% DRP?

LOTEPREDNOL ETABONATE 0.5% DRP (NDC 70748030002) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.